Probucol clinical trials
Also written Lorelco.
How each study uses Probucol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Probucol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 1 Feb 1977 · LORELCO · NDA 017535 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 8
Otsuka Beijing Research Institute (7) · Korea Otsuka Pharmaceutical Co., Ltd. (4) · Guangdong Provincial People's Hospital (2) · Asan Medical Center (2) · Seoul National University Hospital (1) · Douglas Mental Health University Institute (1) · First Affiliated Hospital of Wannan Medical College (1) · General Hospital of Shenyang Military Region (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Probucol.
- Nov 2027The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic PlaquesPhase 4 · General Hospital of Shenyang Military Region
Studies
Open first, then newest update. How each study uses Probucol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 19
- Probucol for Symptomatic Intracranial and Extracranial Artery StenosisRecruitingPhase 3First Affiliated Hospital of Wannan Medical CollegeNCT06225752Written as ProbucolHow we know
- The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic PlaquesRecruitingPhase 4General Hospital of Shenyang Military RegionNCT03753555Written as ProbucolHow we know
- To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia SubjectCompletedPhase 4Otsuka Beijing Research InstituteNCT02098460Written as Atorvastatin, Probucol, CilostazolHow we know
- Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedPhase 4Otsuka Beijing Research InstituteNCT00823849Written as ProbucolHow we know
- Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and SafetyCompletedPhase 2Korea Otsuka Pharmaceutical Co., Ltd.NCT01142284Written as Cilostazol, ProbucolHow we know
- Pharmacokinetics Study for ProbucolCompletedPhase 4Korea Otsuka Pharmaceutical Co., Ltd.NCT01000467Written as probucolHow we know
- Safety and Pharmacokinetics of Probucol and CilostazolCompletedPhase 4Korea Otsuka Pharmaceutical Co., Ltd.NCT00549978Written as ProbucolHow we know
- Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIseaseCompletedPhase 4Seoul National University HospitalNCT01291641Written as ProbucolHow we know
- Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive DeteriorationCompletedPhase 1/2Douglas Mental Health University InstituteNCT02707458Written as ProbucolHow we know
- Efficacy and Safety Study of Probucol in Patients With Diabetic NephropathyCompletedPhase 2Korea Otsuka Pharmaceutical Co., Ltd.NCT01726816Written as Probucol 250mg/dayHow we know
- Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNot applicableGuangdong Provincial People's HospitalNCT00655330Written as ProbucolHow we know
- PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT StudyStatus unknownPhase 4Asan Medical CenterNCT02483169Written as ProbucolHow we know
- PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhageStatus unknownPhase 4Asan Medical CenterNCT01013532Written as ProbucolHow we know
- A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy VolunteersCompletedNot applicableOtsuka Beijing Research InstituteNCT02196805Written as Group A: imported Probucol ( Lorelco)How we know
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedPhase 4Guangdong Provincial People's HospitalNCT00426348Written as ProbucolHow we know
- Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male SubjectsCompletedPhase 1Otsuka Beijing Research InstituteNCT01590901Written as ProbucolHow we know
- Efficacy and Safety of Imported Probucol to Treat HyperlipidemiaCompletedPhase 3Otsuka Beijing Research InstituteNCT01349010Written as ProbucolHow we know
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedPhase 4Otsuka Beijing Research InstituteNCT01252056Written as ProbucolHow we know
- Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedPhase 4Otsuka Beijing Research InstituteNCT00823875Written as Probucol groupHow we know
Codes
What other systems call Probucol · ClinicalTrials.gg INT008091
- MeSH (NLM) D011341ProbucolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P3CTH044XJPROBUCOLConfirmed FDA, NLM, Wikidata
- RxNorm 8699Confirmed FDA, Wikidata
- Wikidata Q10354103probucolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66470ProbucolOne source FDA
- DrugBank DB01599One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011341 | Probucol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P3CTH044XJ | PROBUCOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8699 | — | Confirmed FDA, Wikidata |
| Wikidata | Q10354103 | probucol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66470 | Probucol | One source FDA |
| DrugBank | DB01599 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.